Advertisement
Amgen Says Bone Drug Cut Fractures in Big TrialWall Street Journal - 1 hour agoBy MARILYN CHASE In a summary of results from a big clinical trial, Amgen Inc. said its experimental bone drug shored up skeletal strength and reduced spinal fractures in men undergoing hormone-blocking treatment for prostate cancer.UPDATE 1-Drug prevents bone loss in prostate cancer - Amgen ReutersAmgen Drug Cuts Bone Loss In Prostate Cancer Patients AHNCNNMoney.com - Bizjournals.com - Forbes - Food Consumerall 67 news articles
Discuss   Share This  Tell a friend   Discard



Comments Who Ranked Related Links